Big Pharma Needs A Nudge To Make More Deals In Neuroscience Space
This article was originally published in The Pink Sheet Daily
Executive Summary
Neurology field is a “sleeper” deal category, experts say, with lots of unmet need, scientific advances and even blockbuster opportunities.